type here...

CATEGORIES

Pharmaceutics

LATEST

1234...11Page 3 of 11

TRENDING

EDITORS CHOICE

The 50 Most Influential Leaders in Pharmacy Awards Opens for Nominations

Medika Life -
Nominations for the 50 most influential individuals in Pharma are now open. Join the Pharmacy Podcast Network in celebrating your choices

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Drug Shortages During the Time of Coronavirus

Jennifer Mittler-Lee B.S. Pharma -
An astonishing 82% of drug shortages are listed as reason unknown. The other causes include manufacturing, discontinuation, raw materials, and supply and demand.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories